BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 30510371)

  • 1. Mononuclear phagocyte system in hepatitis C virus infection.
    Yang Y; Tu ZK; Liu XK; Zhang P
    World J Gastroenterol; 2018 Nov; 24(44):4962-4973. PubMed ID: 30510371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mononuclear phagocyte system in hepatocellular carcinoma.
    Qiao DR; Shan GY; Wang S; Cheng JY; Yan WQ; Li HJ
    World J Gastroenterol; 2022 Dec; 28(45):6345-6355. PubMed ID: 36533105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ system view of the hepatic innate immunity in HCV infection.
    Bang BR; Elmasry S; Saito T
    J Med Virol; 2016 Dec; 88(12):2025-2037. PubMed ID: 27153233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
    Wong MT; Chen SS
    Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV immunopathogenesis: virus-induced strategies against host immunity.
    Szabo G; Dolganiuc A
    Clin Liver Dis; 2006 Nov; 10(4):753-71. PubMed ID: 17164116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinforcing the Functionality of Mononuclear Phagocyte System to Control Tuberculosis.
    Pahari S; Kaur G; Negi S; Aqdas M; Das DK; Bashir H; Singh S; Nagare M; Khan J; Agrewala JN
    Front Immunol; 2018; 9():193. PubMed ID: 29479353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity against hepatitis C virus.
    Xu Y; Zhong J
    Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current progress in host innate and adaptive immunity against hepatitis C virus infection.
    Shi J; Li Y; Chang W; Zhang X; Wang FS
    Hepatol Int; 2017 Jul; 11(4):374-383. PubMed ID: 28643186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of hepatitis C virus infections.
    Spaan M; Janssen HL; Boonstra A
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):391-400. PubMed ID: 23199499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus strategies to evade the specific-T cell response: a possible mission favoring its persistence.
    Quarleri JF; Oubiña JR
    Ann Hepatol; 2016; 15(1):17-26. PubMed ID: 26626636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
    Yang DR; Zhu HZ
    World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of innate and adaptive immune responses in beta-thalassemic patients with chronic hepatitis C virus infection.
    Al-Ofairi BA; Barakat AB; Ghanim Hel-D; Shehata IH; El-Sayed MH
    Egypt J Immunol; 2011; 18(1):61-76. PubMed ID: 23082481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV and innate immunity.
    Ebihara T; Matsumoto M; Seya T
    Uirusu; 2008 Jun; 58(1):19-26. PubMed ID: 19122385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells in hepatitis C: Current progress.
    Yoon JC; Yang CM; Song Y; Lee JM
    World J Gastroenterol; 2016 Jan; 22(4):1449-60. PubMed ID: 26819513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
    Golden-Mason L; Rosen HR
    Liver Transpl; 2006 Mar; 12(3):363-72. PubMed ID: 16498647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
    Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
    J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD; Landay AL; Sandberg JK
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune system control of hepatitis C virus infection.
    Stuart JD; Salinas E; Grakoui A
    Curr Opin Virol; 2021 Feb; 46():36-44. PubMed ID: 33137689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C virus subverts pattern recognition receptors-mediated control of adaptative immunity orchestrated by dendritic cells].
    Rodrigue-Gervais IG; Lamarre D
    Med Sci (Paris); 2010 Oct; 26(10):869-74. PubMed ID: 20929679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.